|
| | HR0039 | | LRB097 05553 KXB 45614 r |
|
|
1 | | HOUSE RESOLUTION
|
2 | | WHEREAS, The prescription of psychotropic drugs to treat |
3 | | psychiatric disorders has greatly increased in recent years; |
4 | | and
|
5 | | WHEREAS, The U.S. Food and Drug Administration has, since |
6 | | 2004, required manufacturers of selective serotonin reuptake |
7 | | inhibitor antidepressant medications (SSRIs) to add black box |
8 | | warnings to their product labeling, advising that studies have |
9 | | shown an increase in suicidal thinking and behavior among |
10 | | children and adolescents suffering from psychiatric disorders; |
11 | | and
|
12 | | WHEREAS, Health authorities in Canada, the European Union, |
13 | | Australia, and Great Britain have issued warnings regarding the |
14 | | increased risk of self-harm or harm to others associated with |
15 | | SSRIs; and
|
16 | | WHEREAS, In recent years there have been numerous |
17 | | documented instances of suicides and acts of violence against |
18 | | others by persons reported to have been taking antidepressants |
19 | | and/or other psychotropic medications; therefore, be it
|
20 | | RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE |
21 | | NINETY-SEVENTH GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that |
|
| | HR0039 | - 2 - | LRB097 05553 KXB 45614 r |
|
|
1 | | the Psychotropic Substances Suicide Risk Task Force be created |
2 | | within the Department of Public Health to (1) study and report |
3 | | upon the available research relevant to the reputed causal link |
4 | | between prescription of psychotropic substances and acts of |
5 | | suicide or violence against others; (2) to evaluate whether the |
6 | | State of Illinois' current policies with regard to psychotropic |
7 | | substances are adequate to protect the public; and (3) to make |
8 | | recommendations as to whether Illinois should consider |
9 | | adopting additional policies with regard to psychotropic |
10 | | substances, including but not limited to requiring county |
11 | | coroners to test for psychotropic substances in cases of |
12 | | suspected suicide; and be it further
|
13 | | RESOLVED, That the Task Force shall consist of the |
14 | | following members: 3 members appointed by the Speaker of the |
15 | | House of Representatives, one of whom shall be appointed |
16 | | co-chairperson, and 3 members appointed by the Minority Leader |
17 | | of the House of Representatives, one of whom shall be appointed |
18 | | co-chairperson; and 2 members appointed by the Director of the |
19 | | Department of Public Health; and be it further |
20 | | RESOLVED, That the Task Force shall take voluntary |
21 | | assistance and testimony from individuals and/or professional |
22 | | organizations and institutions; and be it further |
23 | | RESOLVED, That the members of the Task Force shall serve |